FMP
Thermo Fisher Scientific Inc. (NYSE:TMO) Faces Downgrade but Shows Growth Potential
Jul 9, 2025 1:05 AM - Tony Dante
Image credit: Google Images
- UBS downgraded Thermo Fisher Scientific Inc. (NYSE:TMO) to Neutral due to R&D pressures, yet the company exhibits signs of recovery with promising growth prospects.
- Investments in US manufacturing and the acquisition of Solventum highlight Thermo Fisher's strategic moves to enhance capabilities and market reach.
- Despite current margin pressures, Thermo Fisher is focusing on productivity improvements and pricing strategies to mitigate challenges.
Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in serving science, providing innovative solutions for the pharmaceutical, biotechnology, and bioproduction sectors. The company is known for its comprehensive range of products and services that support research, diagnostics, and manufacturing. Thermo Fisher competes with other industry giants like Agilent Technologies and Danaher Corporation.
On July 8, 2025, UBS downgraded TMO to a Neutral grade, citing pressures in research and development. At the time, the stock was priced at $426.17, as reported by TheFly. Despite this downgrade, Thermo Fisher is showing signs of recovery, with promising growth prospects in its core sectors. The company's strategic focus on pharmaceuticals, biotechnology, and bioproduction is expected to drive future growth.
Recent investments in US manufacturing and the acquisition of Solventum are key moves by Thermo Fisher to bolster future opportunities. These investments are aimed at enhancing the company's capabilities and expanding its market reach. Although margins are currently under pressure due to tariffs and strategic investments, Thermo Fisher is implementing productivity improvements and pricing strategies to mitigate these challenges.
The stock price of TMO is currently $426.17, reflecting a 1.78% increase or $7.47. Today, the stock has traded between $418.58 and $433.14. Over the past year, TMO has seen a high of $627.88 and a low of $385.46. The company's market capitalization is approximately $160.88 billion, with a trading volume of 2,616,486 shares on the NYSE.
Other Blogs
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental Analysis: Principles, Types, and How to Use It
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
Dec 22, 2024 7:59 AM - Sanzhi Kobzhan
Two great Software Platform Stocks Similar to Palantir (PLTR)
When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...
Dec 30, 2024 4:32 AM - Sanzhi Kobzhan
Walk Me Through a DCF: A Simple Guide to Discounted Cash Flow Valuation
Are you curious about how professional investors decide whether a stock might be one of the best undervalued stocks to buy now? One of the most popular tools is the Discounted Cash Flow (DCF) model. In this article, I’ll walk you through a DCF step by step. By the end, you’ll see how the Advanced DC...
